Connection

Allen Kaplan to Urticaria

Back to Details
This is a "connection" page, showing publications Allen Kaplan has written about Urticaria.
Allen Kaplan
Connection Strength
15.836
Urticaria
  1. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances. Allergy. 2023 02; 78(2):389-401.
    View in: PubMed
    Score: 0.783
  2. The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells. J Allergy Clin Immunol Pract. 2021 06; 9(6):2195-2208.
    View in: PubMed
    Score: 0.697
  3. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which. J Allergy Clin Immunol Pract. 2021 03; 9(3):1067-1078.
    View in: PubMed
    Score: 0.692
  4. Diagnosis and treatment of chronic spontaneous urticaria. Allergy. 2020 07; 75(7):1830-1832.
    View in: PubMed
    Score: 0.645
  5. Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize. J Allergy Clin Immunol. 2019 08; 144(2):622-623.
    View in: PubMed
    Score: 0.615
  6. Chronic Spontaneous Urticaria: The Devil's Itch. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1097-1106.
    View in: PubMed
    Score: 0.576
  7. Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy Asthma Proc. 2018 May 01; 39(3):184-190.
    View in: PubMed
    Score: 0.569
  8. Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study. J Am Acad Dermatol. 2018 04; 78(4):793-795.
    View in: PubMed
    Score: 0.548
  9. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017 Apr; 72(4):519-533.
    View in: PubMed
    Score: 0.519
  10. Vibratory Urticaria and ADGRE2. N Engl J Med. 2016 07 07; 375(1):94-5.
    View in: PubMed
    Score: 0.502
  11. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol. 2016 Feb; 137(2):474-81.
    View in: PubMed
    Score: 0.477
  12. Biologic agents and the therapy of chronic spontaneous urticaria. Curr Opin Allergy Clin Immunol. 2014 Aug; 14(4):347-53.
    View in: PubMed
    Score: 0.439
  13. Therapy of chronic urticaria: a simple, modern approach. Ann Allergy Asthma Immunol. 2014 May; 112(5):419-25.
    View in: PubMed
    Score: 0.428
  14. The maddening itch: an approach to chronic urticaria. J Investig Allergol Clin Immunol. 2014; 24(1):1-5.
    View in: PubMed
    Score: 0.421
  15. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
    View in: PubMed
    Score: 0.407
  16. Biologic agents in the treatment of urticaria. Curr Allergy Asthma Rep. 2012 Aug; 12(4):288-91.
    View in: PubMed
    Score: 0.382
  17. What to do with refractory urticaria patients. Curr Allergy Asthma Rep. 2011 Jun; 11(3):189-91.
    View in: PubMed
    Score: 0.352
  18. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011 May; 127(5):1300-2.
    View in: PubMed
    Score: 0.345
  19. What the first 10,000 patients with chronic urticaria have taught me: a personal journey. J Allergy Clin Immunol. 2009 Mar; 123(3):713-7.
    View in: PubMed
    Score: 0.297
  20. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
    View in: PubMed
    Score: 0.291
  21. Chronic urticaria: what is new, where are we headed. Allergol Immunopathol (Madr). 2007 Mar-Apr; 35(2):57-61.
    View in: PubMed
    Score: 0.262
  22. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2005 Jun; 94(6):662-9.
    View in: PubMed
    Score: 0.232
  23. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy. 2005 May; 35(5):554-9.
    View in: PubMed
    Score: 0.231
  24. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005 Apr; 115(4):815-21.
    View in: PubMed
    Score: 0.230
  25. Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. A.P. Kaplan. Clin Exp Allergy. 2004 Nov; 34(11):1803; author reply 1804-5.
    View in: PubMed
    Score: 0.223
  26. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004 Sep; 114(3):465-74; quiz 475.
    View in: PubMed
    Score: 0.221
  27. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003 Aug; 58(8):802-7.
    View in: PubMed
    Score: 0.205
  28. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol. 2003 Jul; 112(1):218.
    View in: PubMed
    Score: 0.203
  29. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002 Apr; 109(4):694-700.
    View in: PubMed
    Score: 0.187
  30. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002 Jan; 109(1):114-8.
    View in: PubMed
    Score: 0.183
  31. Immediate pressure urticaria. Allergy. 2002 Jan; 57(1):56-7.
    View in: PubMed
    Score: 0.183
  32. The international EAACI/GA?LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 03; 77(3):734-766.
    View in: PubMed
    Score: 0.181
  33. A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema. J Allergy Clin Immunol Pract. 2021 06; 9(6):2284-2292.
    View in: PubMed
    Score: 0.174
  34. Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence. Allergy. 2020 08; 75(8):2115-2123.
    View in: PubMed
    Score: 0.163
  35. Diagnostic tests for urticaria and angioedema. Clin Allergy Immunol. 2000; 15:111-26.
    View in: PubMed
    Score: 0.160
  36. Pathogenesis and treatment of chronic urticaria. Postgrad Med. 1999 Dec; 106(7 Suppl):12-7.
    View in: PubMed
    Score: 0.159
  37. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol. 1999 Jul; 104(1):169-72.
    View in: PubMed
    Score: 0.154
  38. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998 May; 101(5):672-6.
    View in: PubMed
    Score: 0.142
  39. The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria. J Allergy Clin Immunol. 2018 03; 141(3):1138-1139.e7.
    View in: PubMed
    Score: 0.138
  40. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1715-1721.
    View in: PubMed
    Score: 0.135
  41. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997 Apr; 99(4):461-5.
    View in: PubMed
    Score: 0.132
  42. Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria. Ann Allergy Asthma Immunol. 2017 04; 118(4):524.
    View in: PubMed
    Score: 0.132
  43. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Ann Allergy Asthma Immunol. 2016 10; 117(4):370-377.e1.
    View in: PubMed
    Score: 0.126
  44. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. J Allergy Clin Immunol Pract. 2015 Sep-Oct; 3(5):743-50.e1.
    View in: PubMed
    Score: 0.116
  45. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 07; 368(10):924-35.
    View in: PubMed
    Score: 0.099
  46. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011 Sep; 128(3):567-73.e1.
    View in: PubMed
    Score: 0.089
  47. Unmet clinical needs in chronic spontaneous urticaria. A GA?LEN task force report. Allergy. 2011 Mar; 66(3):317-30.
    View in: PubMed
    Score: 0.085
  48. Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):142-8.
    View in: PubMed
    Score: 0.083
  49. Urticaria: the relationship of duration of lesion to pathogenesis. Allergy Proc. 1990 Jan-Feb; 11(1):15-8.
    View in: PubMed
    Score: 0.080
  50. Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009 Jun; 39(6):777-87.
    View in: PubMed
    Score: 0.076
  51. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988 Feb; 90(2):213-7.
    View in: PubMed
    Score: 0.070
  52. Basophil secretion in chronic urticaria: autoantibody-dependent or not? J Allergy Clin Immunol. 2007 Sep; 120(3):729-30.
    View in: PubMed
    Score: 0.067
  53. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):914-8.
    View in: PubMed
    Score: 0.064
  54. Angioedema. J Am Acad Dermatol. 2005 Sep; 53(3):373-88; quiz 389-92.
    View in: PubMed
    Score: 0.059
  55. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60.
    View in: PubMed
    Score: 0.057
  56. Exercise-induced hives. J Allergy Clin Immunol. 1984 May; 73(5 Pt 2):704-7.
    View in: PubMed
    Score: 0.054
  57. Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984 Apr; 73(4):453-6.
    View in: PubMed
    Score: 0.054
  58. Chronic urticaria. Possible causes, suggested treatment alternatives. Postgrad Med. 1983 Sep; 74(3):209-15, 218-22.
    View in: PubMed
    Score: 0.051
  59. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983 Feb; 71(2):177-83.
    View in: PubMed
    Score: 0.049
  60. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002 Jan 17; 346(3):175-9.
    View in: PubMed
    Score: 0.046
  61. Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol. 1981 Dec; 68(6):438-41.
    View in: PubMed
    Score: 0.046
  62. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981 Oct 29; 305(18):1074-7.
    View in: PubMed
    Score: 0.045
  63. Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol. 1981 Oct; 68(4):319-24.
    View in: PubMed
    Score: 0.045
  64. Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 1981 Aug; 68(2):103-5.
    View in: PubMed
    Score: 0.045
  65. The pathogenic basis of urticaria and angioedema: recent advances. Am J Med. 1981 Apr; 70(4):755-8.
    View in: PubMed
    Score: 0.044
  66. The physical urticarias. Int J Dermatol. 1980 Oct; 19(8):417-35.
    View in: PubMed
    Score: 0.042
  67. The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol. 1980 Apr; 65(4):309-12.
    View in: PubMed
    Score: 0.041
  68. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999 Nov; 104(5):1071-8.
    View in: PubMed
    Score: 0.039
  69. Evaluation of a patient with cold and cholinergic urticaria. J Allergy Clin Immunol. 1979 Jan; 63(1):35-8.
    View in: PubMed
    Score: 0.037
  70. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol. 1978 Jun; 61(6):350-4.
    View in: PubMed
    Score: 0.036
  71. Mediators of urticaria and angioedema. J Allergy Clin Immunol. 1977 Nov; 60(5):324-32.
    View in: PubMed
    Score: 0.034
  72. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975 Jun; 55(6):394-402.
    View in: PubMed
    Score: 0.029
  73. Drug-induced skin disease. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 2):573-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.